Skip to content

BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin

BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin

Post navigation

Previous Previous post: Announcing the establishment of the Department of Metabolism and Physiology at IDAC
Next Next post: Core belief disruption amid the COVID-19 pandemic in Japanese adults
  • About Us
    • IDAC’s Mission Statement
    • Greeting & Mission
    • Notable Alumni
    • History of IDAC
    • IDAC’s Affiliations
  • News & Events
  • Research Facilities & Faculty
    • Research Facilities
    • Common Facilities
  • Resources & Equipment
    • Brain Imaging
    • Cell Center
    • Equipment
  • Admission & Courses
    • Mechanisms of Aging
    • Overcoming Intractable Cancers
    • Overcoming Age-Related Brain Diseases
    • Achieving “Smart-Aging”
  • Public Relations & Info. Office
  • Maps & Directions
  • Give to IDAC
  • Contact Us
  • Privacy Policy & Disclaimer
  • IDAC COVID-19 Update
  • About Us
    • IDAC’s Mission Statement
    • Greeting & Mission
    • Notable Alumni
    • History of IDAC
    • IDAC’s Affiliations
  • News & Events
  • Research Facilities & Faculty
    • Research Facilities
    • Common Facilities
  • Resources & Equipment
    • Brain Imaging
    • Cell Center
    • Equipment
  • Admission & Courses
    • Mechanisms of Aging
    • Overcoming Intractable Cancers
    • Overcoming Age-Related Brain Diseases
    • Achieving “Smart-Aging”
  • Public Relations & Info. Office
  • Maps & Directions
  • Give to IDAC
  • Contact Us
  • Privacy Policy & Disclaimer
  • IDAC COVID-19 Update
English Japanese
©Institute of Development, Aging and Cancer, Tohoku University